BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Cipla
Dow
McKinsey
Healthtrust
Novartis
Merck
Johnson and Johnson
AstraZeneca
McKesson

Generated: January 22, 2018

DrugPatentWatch Database Preview

Amneal Pharm Company Profile

« Back to Dashboard

What is the competitive landscape for AMNEAL PHARM, and what generic and branded alternatives to AMNEAL PHARM drugs are available?

AMNEAL PHARM has one hundred and seventy-two approved drugs.

There are twelve tentative approvals on AMNEAL PHARM drugs.

Summary for Amneal Pharm
US Patents:0
Tradenames:132
Ingredients:127
NDAs:172

Drugs and US Patents for Amneal Pharm

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms Co BUMETANIDE bumetanide TABLET;ORAL 209724-002 Oct 18, 2017 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Amneal Pharms Llc ACTIVELLA estradiol; norethindrone acetate TABLET;ORAL 020907-002 Dec 28, 2006 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Amneal Pharms Ny CITALOPRAM HYDROBROMIDE citalopram hydrobromide TABLET;ORAL 077289-001 Nov 30, 2006 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Amneal Pharms ESCITALOPRAM OXALATE escitalopram oxalate TABLET;ORAL 205619-001 May 17, 2017 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Amneal Pharms MEMANTINE HYDROCHLORIDE memantine hydrochloride TABLET;ORAL 090041-001 Apr 10, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Amneal Pharms Ny METFORMIN HYDROCHLORIDE metformin hydrochloride TABLET, EXTENDED RELEASE;ORAL 078596-001 Jan 3, 2008 AB1 RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Amneal Pharms EPTIFIBATIDE eptifibatide INJECTABLE;INJECTION 205581-001 Dec 8, 2016 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Amneal Pharms Ny OXYCODONE AND ACETAMINOPHEN acetaminophen; oxycodone hydrochloride TABLET;ORAL 040778-002 Jun 27, 2014 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Amneal Pharms Ny HYDROCODONE BITARTRATE AND ACETAMINOPHEN acetaminophen; hydrocodone bitartrate TABLET;ORAL 040746-002 May 10, 2016 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Amneal Pharms DICLOFENAC SODIUM diclofenac sodium SOLUTION;TOPICAL 206116-001 Sep 2, 2016 AT RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cipla
Cantor Fitzgerald
UBS
Chinese Patent Office
Merck
Deloitte
Medtronic
AstraZeneca
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot